Clarkston Consulting and Babson College are working together to execute a market survey on perceptions related to generic biologic drugs, also known as biosimilars. Understanding market perceptions and the potential for adoption in the US are major areas of focus for generic drug companies. Clarkston plans to use the results of this survey to provide the generics industry with insights and areas they should focus on as well as to maximize both the health and financial benefits of this exciting new category of generic alternative drugs. [link-boxes]

If you haven’t already, please take a moment to fill out the survey. You will note that there are links below for both patient and physician surveys. Patient surveys can be filled out by anyone. Physician surveys should be sent to doctors or other medical professionals you may know.

Patient Survey: http://babson.qualtrics.com/SE/?SID=SV_783DsNGeREsKLA1

Physician Survey: http://babson.qualtrics.com/SE/?SID=SV_6lC4SGww1kyoOO1

The survey closes on Tuesday, November 6^th and results will be available in January of 2013. If you have questions or would like to learn more about the survey itself please don’t hesitate to let me know on the blog or at JoeD@clarkstonconsulting.com. Also, all individual responses to the survey are confidential and only will be used in aggregate. However, if you would like to receive an advanced copy of the survey results and analysis, please don’t hesitate to let me know that as well via blog or at JoeD@clarkstonconsulting.com.